Skip to content

Clinical trials

Phase 2 Mastocytosis, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Phase: Phase 2 Country / region: Belgium Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cogent Biosciences, Inc.2
Blueprint Medicines Corporation1
Novartis Pharmaceuticals1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic5
Hematologic Diseases2
Hypersensitivity2
Immune Complex Diseases2
Immune System Diseases2
Leukemia2
Leukemia, Mast-Cell2
Mastocytosis2
Hematologic Neoplasms1
Leukemia, Myeloid1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.